Xarelto Lawsuit Consolidation Completed By JPMDL

BloodThinnerHelp.com reports on the immense number of cases being filed against Bayer AG and Johnson and Johnson Corporation subsidiary, Janssen Pharmaceuticals related to Xarelto, a blood-thinning drug, which has been alleged to have caused instances of uncontrolled and very dangerous bleeding in patients using it. Resulting from a large number of cases, a group of plaintiffs that had filed individual lawsuits petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) in October 2015 to consider the consolidation of the cases since all of the 2,800 and more cases filed involved the same defendants and very similar allegations about the drug.

The petitioners in the multidistrict consolidation litigation (MDL) asked that all the cases involved be under the jurisdiction of a court in the Southern District of Illinois. However, the defendants in the case argued against this move since they were located in New Jersey and felt it would be more prudent to have them assigned to a New Jersey court.

In a decision handed down on December 12, 2015, the judicial panel agreed with the petitioners and opted to consolidate and centralize all the bleeding cases involving Xarelto to the Honorable U.S. District Court Judge Eldon E. Fallon in the eastern District of Louisiana. The panel expressed its confidence in Judge Fallon to prudently and effectively oversee the consolidation since he was very experienced with MDL and was willing and able to do so.

The panel felt that having each case heard individually would only serve to increase the amount of time spent by those parties involved in the cases as well as the legal expenses that would be incurred. The panel also felt such a consolidation would reduce lengthy and sometimes very expensive discovery processes.

To request additional information on Xarelto bleeding lawsuits, or to ask questions at any time, contact Joseph Osborne, Esq. by calling (866) 425-8902.